Rockwell Medical Profit Margin

The latest profit margin for RMTI is -7.99% as of March 2026. That compares with -0.33% in the prior-year period — down 2325.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Rockwell Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, RMTI's profit margin moved from -0.33% to -7.99% — a 2325.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Rockwell Medical's valuation or profitability profile.

Against Healthcare companies, RMTI currently prints -7.99% for profit margin, while the sector average sits near 14.34%. That is roughly 155.7% below the sector mean. Large gaps often invite a closer look at Rockwell Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Rockwell Medical converts resources into returns. At -7.99%, RMTI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -0.33% in the prior-year period — down 2325.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RMTI's profit margin (-7.99%), review year-over-year change from -0.33%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.